Abstract
Despite a prodigious amount of work on the physiology of IgA production in man, and many studies on the immunopathology of IgA nephropathy, ranging from the immunogenetics to the immune response to chemical characteristics of the IgA, we are hardly any nearer to defining the pathogenesis of this disease. One of the main changes in our understanding has been to recognise that the bone marrow, now known to produce normally one-third of the body's IgA, overproduces this immunoglobulin in IgA nephropathy. This alters the previous notion that IgA nephropathy was due simply to IgA production in the mucosa, although a mucosal component is not excluded. Certain characteristics of the IgA in the diseased kidney and the circulation have been defined: it is of subclass IgA1 and has a higher proportion of λ light chains and negative charge than in normal subjects. The specificities of the IgA, either in the kidney or in complexes, have not helped to clarify the pathogenesis. They have been found for a wide range of endogenous and exogenous antigens, suggesting that the antibody activity represents polyclonal B cell activation. These findings have not helped to confirm the prevailing theory that IgA nephropathy is an immune complex disease. Other theories put forward are that IgA nephropathy is an autoimmune disease, glomerular components or IgA itself being among the candidate antigens, or that there is primary dysregulation of the IgA immune system. At this stage of development in our understanding of this common nephropathy, it is important to guard against the assumption that idiopathic IgA nephropathy is one disease and is the result of a single pathogenetic mechanism.
Similar content being viewed by others
References
Disney APS (ed) (1989) Twelfth report of the Australian and New Zealand combined dialysis and transplant registry. Published at the Queen Elizabeth Hospital, Woodville, South Australia
Russell MW, Lue C, Van Den Wall Bakke AWL, Moldoveanu Z, Mestecky J (1992) Molecular heterogeneity of human IgA antibodies during an immune response. Clin Exp Immunol 87:1–6
Rajaraman S, Goldblum RM, Cavallo T (1986) IgA-associated glomerulonephritides: a study with monoclonal antibodies. Clin Immunol Immunopathol 39:514–522
Lai KN, Chan KW, Lai FM, Ho CP, Yan KW, Lam CWK, Vallance-Owen J (1986) The immunochemical characterisation of the light chains in the mesangial IgA deposits in IgA nephropathy. Am J Clin Pathol 85:548–551
Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P (1985) Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28:666–671
Sato M, Kojima H, Takayama K, Koshikawa S (1988) Glomerular deposition of food antigens in IgA nephropathy. Clin Exp Immunol 73:295–299
Nagy J, Vj M, Szucs G, Trinn C, Burger T (1984) Herpes antigens and antibodies in kidney biopsies and sera of IgA glomerulonephritis patients. Clin Nephrol 21:259–262
Tomino Y, Yagame M, Omata F, Nomoto Y, Sakai H (1987) A case of IgA nephropathy with adeno- and herpes simplex viruses. Nephron 47:258–261
Woodroffe AJ, Gormley AA, McKenzie PE, Wootton AM, Thompson AJ, Seymour AE, Clarkson AR (1980) Immunological studies in IgA nephropathy. Kidney Int 18:366–374
Chui SH, Lam CWK, Lewis WHP, Lai KN (1991) Light-chain ratio of serum IgA1 in IgA nephropathy. J Clin Immunol 11:219–223
Chen N, Nusbaum P, Halbwachs-Mecarelli L, Lesavre P (1991) Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy. Nephrol Dial Transplant 6:846–850
Delacroix DL, Elkon KB, Geubel AP, Hodgson HF, Dive C, Vaerman JP (1983) Change in size, sub-class and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest 71:358–367
Danielsen H, Eriksen EF, Johansen A, Solling J (1984) Serum immunoglobulin sedimentation patterns and circulating immune complexes in IgA nephropathy and Henoch-Schonlein nephritis. Acta Med Scand 215:435–441
Lesavre P, Digeon M, Bach JF (1982) Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol 48:61–69
Feehally J, Beattie TJ, Brenchley PEC, Coupes BM, Mallick NP, Postlethwaite RJ (1986) Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int 30:924–931
Harada T, Hobby P, Courteau M, Knight JF, Williams DG (1989) Charge distribution of plasma IgA in IgA nephropathy. Clin Exp Immunol 77:211–214
Finlayson G (1975) Immunoglobulin A glomerulonephritis — a clinico-pathologic study. Lab Invest 32:140–148
Tomino Y, Endoh M, Kaneshige H, Nomoto Y, Sakai H (1986) Increase of IgA in pharyngeal washings from patients with IgA nephropathy. Am J Med Sci 286:15–21
Whitworth JA, Leibowitz S, Kennedy MC, Cameron JS, Chantler C (1976) IgA and glomerular disease. Clin Nephrol 5:33–36
Westberg NG, Baklien K, Schmekel B, Gillberg R, Brandtzaeg P (1983) Quantitation of immunoglobulin-producing cells in the small intestinal mucosa of patients with IgA nephropathy. Clin Immunol Immunopathol 26:442–445
Ballardie FW (1991) IgA nephropathies and Henoch-Schonlein purpura. In: Pusey CD, Whaley K (eds) Immunology of renal disease. Kluwer, London, pp 183–214
Czerkinsky C, Koopman WJ, Jackson S, Collins JE, Crago SS, Schroehenloher RE, Julian BA, Galla JH, Mestecky J (1986) Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin nephropathies. J Clin Invest 77:1931–1938
Schena FP, Pastore A, Ludovico N, Sinico RA, Benuzzi S, Montinaro V (1989) Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary nephropathy. Clin Exp Immunol 77:15–20
Nicholls K, Kincaid-Smith P (1984) Defective in vivo Fc and C3b-receptor function in IgA nephropathy. Am J Kidney Dis 4:128–134
Rifai A, Schena FP, Montinaro V, Mele M, D'Addabbo D, Nitti L, Pezzullo JC (1989) Clearance kinetics and fate of macromolecular IgA in patients with IgA nephropathy. Lab Invest 61:381–388
Roccatello D, Picciotto G, Coppo R, Piccoli G, Molino A, Cacace G, Amore A, Quattrochio G, Ropoco R, Mosso R, Ameroso A, Sena LM (1991) The fate of aggregated immunoglobulin A injected in IgA nephropathy patients and healthy controls. Am J Kidney Dis 18:12–19
Feehally J, Beattie TJ, Brenchley PEC, Coupes BM, Mallick NF, Postlethwaite RJ (1987) Response of circulating immune complexes to food challenge in relapsing IgA nephropathy. Pediatr Nephrol 11: 581–586
Yap HK, Sakai RS, Woo KT, Lim CH, Jordon SC (1987) Detection of bovine serum albumin in the circulating immune complexes of patients with IgA nephropathy. Clin Immunol Immunopathol 43:395–402
Cederholm B, Wieslander J, Bygren P, Heinegard D (1988) Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA 85:4865–4868
Davin JC, Li-Vecchi M, Nagy J (1991) Evidence that the interaction between circulating IgA and fibronectin is a normal process enhanced in primary IgA nephropathy. J Clin Immunol 11:78–94
Coppo R, Amore M, Roccatello D, Gianoglio B, Molino M, Piccoli G, Clarkson AR, Woodroffe AJ, Sakai H, Tomino Y (1991) IgA antibodies to dietary antigens and lectin-binding IgA in sera from Italian, Australian and Japanese IgA nephropathy patients. Am J Kidney Dis 17:480–487
Tomino Y, Endoh M, Nomoto Y, Sakai H (1982) Specificity of eluted antibody from renal tissues of patients with IgA nephropathy. Am J Kidney Dis 1:276–280
Tomino Y, Koide H, Yagame M, Sakai H, Tanaka S (1990) Preliminary study on specificity of IgA released from lymphocytes by BB virus transformation in patients with IgA nephropathy. Am J Med Sci 299:374–378
Cosio FG, Lam S, Folami AO, Conley ME, Michael AF (1982) Immune regulation of immunoglobulin production in IgA nephropathy. Clin Immunol Immunopathol 23:430–436
Nomoto Y, Sakai H, Arimori S (1979) Increase of IgA-bearing lymphocytes in peripheral blood from patients with IgA nephropathy. Am J Clin Pathol 71:158–160
Magyarlaki T, Davin JC, Szabados E, Kocsis B, Nagy J (1990) Peripheral B lymphocyte markers and function in IgA nephropathy Clin Nephrol 33:123–129
Rothschild E, Chatenoud L (1984) T cell subset modulation of immunoglobulin production in IgA nephropathy and membranous glomerulonephritis. Kidney Int 25:557–564
Sakai H, Endoh Y, Tomino Y, Nomoto Y (1982) Increase of IgA specific helper Tα cells in patients with IgA nephropathy. Clin Exp Immunol 50:77–82
Sakai H, Miyazaki M, Endoh M, Nomoto Y (1989) Increase of IgA-specific switch T cells in patients with IgA nephropathy. Clin Exp Immunol 78:378–382
Egido J, Blasco R, Sancho J, Lozano L (1983) T-cell dysfunctions in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis. Clin Immunol Immunopathol 26:201–212
Sakai H, Nomoto Y, Arimori S (1979) Decrease of IgA specific suppressor T cell activity in patients with IgA nephropathy. Clin Exp Immunol 38:243–248
Fortune F, Courteau M, Williams DG, Lehner T (1992) T and B cell responses following immunisation with tetanus toxoid in IgA nephropathy. Clin Exp Immunol 88:62–67
Lai KN, Lai FM, Chui SH, Chan YM, Tsao GSW, Leung KN, Lam CWK (1987) Studies of lymphocyte subpopulations and immunoglobulin production in IgA nephropathy. Clin Nephrol 28:281–287
Yano N, Endoh M, Miyazaki M, Yamouchi F, Nomoto Y, Sakai H (1992) Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy. Clin Exp Immunol 88:295–300
Cagnoli L, Beltrandi E, Pasquali S, Biagi R, Casadei-Maldini M, Rossi L, Zucchelli P (1985) B and T cell abnormalities in patients with primary IgA nephropathy. Kidney Int 28:646–651
Van den Wall Bakke AWL, Daha MR, Radl J, Haaijman JJ, Van der Ark A, Valentijn RM, Van Es LA (1988) The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol 72:321–325
Bene MC, Faure GC, Hurault de Ligney B, Kessler U, Duheille J (1983) Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of IgA versus IgG secreting cell balance. J Clin Invest 71:1342–1347
Nagy J, Brandtzaeg P (1988) Tonsillar distribution of IgA and IgG immunocytes and production of IgA subclasses and J chain in tonsillitis vary with the presence or absence of IgA nephropathy. Scand J Immunol 27:393–399
Monteiro RC, Kubagawa H, Cooper MD (1990) Cellular distribution, regulation and biochemical nature of an Fcα receptor in humans. J Exp Med 171:597
Schena FP, Mastrolitti G, Jirillo E, Munno I, Pellegrino N, Fragasso AR, Aventaggiato L (1989) Increased production of interleukin 2 and IL-2 receptor in primary IgA nephropathy. Kidney Int 35: 875–879
Lai KN, Leung JCK, Li PKT, Lui SF (1991) Cytokine production by peripheral blood mononuclear cells in IgA nephropathy. Clin Exp Immunol 85:240–245
Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoto Y, Yoshizaki K, Hirano T, Kighimoto T (1989) Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143:3949–3955
Leinikki PO, Mustonen M, Pasternack A (1987) Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Clin Exp Immunol 68:33–38
Van Den Wall Bake AWL, Beyer WEP, Evers-Schouten JH, Hermans J, Daha MR, Masurel N, Van Es LA (1989) Humoral immune response to influenza vaccination in patients with primary IgA nephropathy. J Clin Invest 84:1070–1075
Pasternack A, Mustonen J, Leinikki PO (1986) Humoral immune response in patients with IgA and IgM glomerulonephritis. Clin Exp Immunol 63:228–233
Layward L, Allen AC, Harper SJ, Hattersley JM, Feehally J (1992) Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy. Clin Exp Immunol 88:394–398
McLean RH, Wyatt RJ, Julian BA (1984) Complement phenotypes in glomerulonephritis: increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schonlein purpura. Kidney Int 26:855–860
Rambausek M, Van den Wall Bakke AWL, Schumacher-Ach R, Spitzenberg R, Rother H, Van Es LA, Ritz E (1987) Genetic polymorphism of C4 and Bf in IgA nephropathy. Nephrol Dial Transplant 2:208–211
Wyatt RJ, Julian BA, Galla JH, McLean RH (1984) Increased frequency of C3 fast alleles in IgA nephropathy. Dis Markers 2:419–428
Li PKT, Burns AP, So AKL, Pusey CD, Feehally J, Rees AJ (1991) The DQw7 allele at the HLA DQB locus is associated with susceptibility to IgA nephropathy in Caucasians. Kidney Int 39:961–965
Demaine AG, Rambausek M, Knight JF, Williams DG, Welsh KI, Ritz E (1988) Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region. J Clin Invest 81:611–614
Hitman G, Moore R, Richards N, Lucas E, Venning M, Goodship T, Cunningham J, Marsh F (1989) Immunoglobulin heavy chain switch region gene polymorphisms in idiopathic membranous nephropathy and IgA nephropathy. Kidney Int 35:349
Berger J (1988) Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 12:371–372
Silva FG, Chandler P, Pirani CL, Hardy A (1982) Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 33:214–216
Jessen RH, Nedrud JG, Emancipator SN (1987) A mouse model of IgA nephropathy induced by Sendai virus. Adv Exp Med Biol 216:1609–1618
Melvin T, Burke B, Michael AF, Kim Y (1983) Experimental IgA nephropathy in bile duct ligated rats. Clin Immunol Immunopathol 27:369–377
Rifai A (1987) Experimental models for IgA-associated nephritis. Kidney Int 31:1–7
Coppo R, Amore A, Roccatello D (1992) Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 2:5173–5180
Clarkson AR, Woodroffe AJ (1987) Treatment tentatives in IgA nephropathy. Semin Nephrol 7:393–398
Ballardie FW, Brenchley PEC, Williams S, O'Donoghue DJ (1988) Autoimmunity in IgA nephropathy. Lancet II:588–591
Egido J, Sancho J, Rivera F, Hernando L (1984) The role of IgA and IgG immune complexes in IgA nephropathy. Nephron 36:52–59
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, D.G. Pathogenesis of idiopathic IgA nephropathy. Pediatr Nephrol 7, 303–311 (1993). https://doi.org/10.1007/BF00853230
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00853230